Handelsavisen
prelaunch
49
4929.T Tokyo Stock Exchange Personal Products

Adjuvant Holdings Co Ltd

¥725,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,61 %
Op margin
0,2 %
ROE
0,3 %
Net margin
1,3 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Adjuvant Holdings Co Ltd operates in the personal products industry, providing consumer goods and services within the personal care segment.

Business. Adjuvant Holdings Co Ltd (4929.T) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, classified under the Personal & Household Products & Services industry group. Headquartered in Japan, the company is primarily listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorPersonal & Household Products & Services
IndustryPersonal Products
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
0,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 4929.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 4929.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Adjuvant Holdings Co Ltd (4929.T) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, classified under the Personal & Household Products & Services industry group. Headquartered in Japan, the company is primarily listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorPersonal & Household Products & Services
    IndustryPersonal Products
    AI synthesis
    GENERATED

    Adjuvant Holdings Co Ltd maintains a strong liquidity position, with a current ratio of 5.33, indicating the company can easily cover its short-term liabilities with its current assets. The company holds JPY 2,076,694,000 in cash and equivalents, which is a significant portion of its total assets of JPY 5,266,897,000. The absence of long-term debt further supports its liquidity profile, with a debt-to-equity ratio of 0.0.

    The company's profitability is modest, with a return on equity (ROE) of 0.33% and a return on assets (ROA) of 0.26%. These figures are below the typical thresholds for strong performance in the personal care products industry, suggesting that the company is not generating significant returns relative to its equity or asset base.

    Geographically and segment-wise, the company's exposure is not disclosed in the available data, but its revenue concentration is not specified. The lack of segmental or geographic breakdown limits the ability to assess diversification risks or growth opportunities.

    The company's growth trajectory is not clearly defined in the available data. While the most recent revenue is reported at JPY 1,062,896,000, there is no historical data provided to assess year-over-year growth or future projections. The absence of analyst estimates for future revenue or earnings also limits the ability to forecast performance.

    Risk factors for the company are currently low, with no immediate liquidity or dilution flags detected. The company has no long-term debt and a low dilution risk, with basic and diluted shares outstanding being equal at 8,000,395. No adjustments were applied to the valuation metrics, indicating that the financials are presented without material adjustments.

    Recent events or filings are not disclosed in the available data, and there are no transcripts or other public disclosures provided to assess management commentary or strategic direction. The lack of recent events or filings suggests a stable but potentially uneventful operating environment.

    Key takeaways
    • Adjuvant Holdings Co Ltd has a strong liquidity position with a current ratio of 5.33 and no long-term debt.
    • The company's profitability is low, with ROE and ROA at 0.33% and 0.26%, respectively.
    • There is no disclosed segmental or geographic revenue breakdown, limiting visibility into diversification.
    • The company's growth trajectory is unclear due to the absence of historical revenue data and analyst estimates.
    • Risk factors are currently low, with no liquidity or dilution flags detected.
    • Recent events or filings are not disclosed, suggesting a stable but potentially uneventful operating environment.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Net income surged 251.1% year-over-year to JPY 143 million in FY2026, demonstrating strong bottom-line recovery.

    Free cash flow improved by 132.6% to JPY 93 million in FY2026, indicating enhanced operational cash generation.

    Operating income grew 38.8% to JPY 171 million in FY2026, signaling improved core business profitability.

    The company maintains a zero debt-to-equity ratio, placing it in the top quartile for financial leverage safety.

    Long-term debt decreased to JPY 21.7 million in FY2026, reducing financial obligations and interest burden.

    BEAR CASE · 2

    Operating margin of 0.18% falls significantly below the 5.17% median for the Personal Products cohort.

    Revenue has contracted at a 3.7% CAGR over four years, highlighting a long-term structural decline.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-04-17
    Q1 2026 · Quarter highlights

    Revenue ¥691.7M, −18,4% YoY; Operating income −23,7% YoY.

    Revenue¥691.7M−18,4 % YoY
    Operating income-¥93.0M−23,7 % YoY
    Net income-¥58.6M+10,6 % YoY
    Free cash flow
    EPS
    Operating cash flow¥132.9M−56,8 % YoY
    Financials
    Income statement
    Revenue¥691.7M
    Gross profit¥459.1M
    Operating income-¥93.0M
    Net income-¥58.6M
    Margins
    Gross margin66.4%
    Operating margin-13.4%
    Net margin-8.5%
    FCF margin
    Balance sheet
    Total assets¥5.15B
    Total liabilities¥929.8M
    Total equity¥4.22B
    Cash & equivalents¥2.13B
    Long-term debt¥21.7M
    Cash flow
    Operating cash flow¥132.9M
    CapEx-¥43.0M
    Free cash flow
    SBC
    P&L flow · revenue → net income
    Revenue ¥691.7MOperating costs ¥784.7MNet income ¥58.6M
    Highlights
    • Revenue ¥691.7M, −18,4% YoY
    • Operating income −23,7% YoY
    • Net income +10,6% YoY
    • Net margin -8.5%

    Valuation TTM

    Market price
    ¥725,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥4.14B
    Net cash
    ¥2.08B
    Current ratio
    5.3
    Debt / equity
    0.0
    ROA
    0.3%
    ROE
    0.3%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin0,2 %Below median
    Net Margin1,3 %Below median
    ROE0,3 %Below median
    D/E0,00Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Return On Assets
      net_income / total_assets
    Source documents
    • Adjuvant Holdings Co Ltd Market data — financials · 2026-05-26
    • Adjuvant Holdings Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    4929.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-04-17 12:00 UTCEARNINGSQuarterly results — Q1 2026 Revenue JPY 691.7M · Net JPY -58.6M
    2026-04-17 12:00 UTCEARNINGSAnnual results — FY 2026 Revenue JPY 3.81B · Net JPY 143.0M
    2026-01-16 12:00 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 1.27B · Net JPY 185.6M
    2025-10-17 12:00 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 897.9M · Net JPY 4.7M
    2025-07-18 12:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 958.1M · Net JPY 11.3M
    2025-04-18 12:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 847.3M · Net JPY -65.5M
    2025-04-18 12:00 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 4.10B · Net JPY 40.7M
    2025-01-17 12:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 1.17B · Net JPY 88.0M
    2024-10-18 11:30 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 1.02B · Net JPY 4.7M
    2024-07-19 11:30 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 1.06B · Net JPY 13.5M
    2024-04-19 11:30 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 4.44B · Net JPY -99.9M
    2023-04-21 11:30 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 4.38B · Net JPY 403.6M
    2022-04-22 11:30 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 4.43B · Net JPY 393.2M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage